BB Biotech AG

DB:BBZA Stock Report

Market Cap: €2.3b

BB Biotech Future Growth

Future criteria checks 5/6

BB Biotech is forecast to grow earnings and revenue by 83.5% and 51.9% per annum respectively. EPS is expected to grow by 67.5% per annum. Return on equity is forecast to be 4.1% in 3 years.

Key information

83.5%

Earnings growth rate

67.5%

EPS growth rate

Capital Markets earnings growth6.3%
Revenue growth rate51.9%
Future return on equity4.1%
Analyst coverage

Low

Last updated19 Apr 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:BBZA - Analysts future estimates and past financials data (CHF Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2025101722322322
12/31/20241901521931931
12/31/20230-207218218N/A
9/30/20230-351159159N/A
6/30/20230-92185185N/A
3/31/20230-312213213N/A
12/31/20220-358231231N/A
9/30/2022-187-869190190N/A
6/30/2022-380-1,287213213N/A
3/31/2022-236-926226226N/A
12/31/2021N/A-405-95-95N/A
9/30/2021867806190190N/A
6/30/20216776197171N/A
3/31/20211,7241,670180180N/A
12/31/2020742691262262N/A
9/30/2020581532291291N/A
6/30/2020964545385385N/A
3/31/2020-598-970231231N/A
12/31/2019728677215215N/A
9/30/2019-43-471155155N/A
6/30/2019211153140140N/A
3/31/20195823909595N/A
12/31/20185-471108108N/A
9/30/201811416-128-128N/A
6/30/2018234139-170-170N/A
3/31/2018347341189189N/A
12/31/2017730688263263N/A
9/30/2017875819N/A347N/A
6/30/2017901846N/A494N/A
3/31/2017433778N/A189N/A
12/31/20169-802N/A115N/A
9/30/2016530-266N/A30N/A
6/30/2016130-1,234N/A-282N/A
3/31/2016265-932N/A-146N/A
12/31/2015697653N/A53N/A
9/30/2015908868N/A244N/A
6/30/20151,3971,926N/A457N/A
3/31/20151,8181,784N/A310N/A
12/31/20141,4981,470N/A122N/A
9/30/2014867844N/A87N/A
6/30/2014722700N/A30N/A
3/31/2014660639N/A49N/A
12/31/2013950932N/A117N/A
9/30/2013719697N/A65N/A
6/30/2013529507N/A126N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BBZA is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.6%).

Earnings vs Market: BBZA is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: BBZA is expected to become profitable in the next 3 years.

Revenue vs Market: BBZA's revenue (51.9% per year) is forecast to grow faster than the German market (5.4% per year).

High Growth Revenue: BBZA's revenue (51.9% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: BBZA's Return on Equity is forecast to be low in 3 years time (4.1%).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.